Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $1.15 billion. The enterprise value is $888.61 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IOVA has 327.88 million shares outstanding. The number of shares has increased by 23.28% in one year.
Current Share Class | 327.88M |
Shares Outstanding | 327.88M |
Shares Change (YoY) | +23.28% |
Shares Change (QoQ) | +0.53% |
Owned by Insiders (%) | 8.99% |
Owned by Institutions (%) | 60.54% |
Float | 251.87M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.22 |
Forward PS | 2.49 |
PB Ratio | 1.51 |
P/TBV Ratio | 2.70 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 5.42 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.08.
Current Ratio | 3.74 |
Quick Ratio | 3.21 |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.48% and return on invested capital (ROIC) is -34.57%.
Return on Equity (ROE) | -57.48% |
Return on Assets (ROA) | -29.22% |
Return on Invested Capital (ROIC) | -34.57% |
Return on Capital Employed (ROCE) | -50.16% |
Revenue Per Employee | $195,788 |
Profits Per Employee | -$444,125 |
Employee Count | 838 |
Asset Turnover | 0.19 |
Inventory Turnover | 4.01 |
Taxes
Income Tax | -2.83M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.09% in the last 52 weeks. The beta is 0.93, so IOVA's price volatility has been similar to the market average.
Beta (5Y) | 0.93 |
52-Week Price Change | -76.09% |
50-Day Moving Average | 5.63 |
200-Day Moving Average | 8.34 |
Relative Strength Index (RSI) | 22.83 |
Average Volume (20 Days) | 11,798,919 |
Short Selling Information
The latest short interest is 63.60 million, so 19.40% of the outstanding shares have been sold short.
Short Interest | 63.60M |
Short Previous Month | 63.91M |
Short % of Shares Out | 19.40% |
Short % of Float | 25.25% |
Short Ratio (days to cover) | 6.16 |
Income Statement
In the last 12 months, IOVA had revenue of $164.07 million and -$372.18 million in losses. Loss per share was -$1.28.
Revenue | 164.07M |
Gross Profit | 40.08M |
Operating Income | -395.28M |
Pretax Income | n/a |
Net Income | -372.18M |
EBITDA | -362.11M |
EBIT | -395.28M |
Loss Per Share | -$1.28 |
Full Income Statement Balance Sheet
The company has $323.78 million in cash and $58.26 million in debt, giving a net cash position of $265.52 million or $0.81 per share.
Cash & Cash Equivalents | 323.78M |
Total Debt | 58.26M |
Net Cash | 265.52M |
Net Cash Per Share | $0.81 |
Equity (Book Value) | 710.41M |
Book Value Per Share | 2.33 |
Working Capital | 334.68M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$352.98 million and capital expenditures -$11.07 million, giving a free cash flow of -$364.05 million.
Operating Cash Flow | -352.98M |
Capital Expenditures | -11.07M |
Free Cash Flow | -364.05M |
FCF Per Share | -$1.11 |
Full Cash Flow Statement Margins
Gross margin is 24.43%, with operating and profit margins of -240.92% and -226.84%.
Gross Margin | 24.43% |
Operating Margin | -240.92% |
Pretax Margin | -228.56% |
Profit Margin | -226.84% |
EBITDA Margin | -220.70% |
EBIT Margin | -240.92% |
FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.28% |
Shareholder Yield | -23.28% |
Earnings Yield | -32.25% |
FCF Yield | -31.54% |
Dividend Details Analyst Forecast
The average price target for IOVA is $20.25, which is 475.28% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $20.25 |
Price Target Difference | 475.28% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | 54.28% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 0.01:1.
Last Split Date | Sep 26, 2013 |
Split Type | Reverse |
Split Ratio | 0.01:1 |
Scores
IOVA has an Altman Z-Score of 4.33 and a Piotroski F-Score of 4.
Altman Z-Score | 4.33 |
Piotroski F-Score | 4 |